Zwiers Regulatory Consultancy

Zwiers Regulatory Consultancy provides comprehensive regulatory affairs and pharmacovigilance consulting services across the full drug and device lifecycle. Their expertise spans early development through post-marketing compliance for pharmaceuticals, biologics/ATMPs, and medical devices. They are recognized for strategic advice, dossier preparation/submission (e.g., IND/IMPD/MAA/BLA), pharmacovigilance systems setup and management, regulatory intelligence/training, and supporting global clients with EU specialization. The company was acquired by ProductLife Group in October 2022 to expand PLG’s footprint in the Netherlands and enhance its global regulatory services offering. No proprietary clinical results or pipeline as they are a consultancy.